Publication:
DEVELOPMENT OF A VALIDATED RP-HPLC METHOD FOR THE DETERMINATION OF TIAGABINE AND ITS DEGRADED FORMS IN BULK AND PHARMACEUTICAL DOSAGE FORMS

dc.contributor.authorRAJAKUMARI A/P RAJASINGAM
dc.date.accessioned2023-10-06T15:20:53Z
dc.date.available2023-10-06T15:20:53Z
dc.date.issued2015-05
dc.description.abstractA simple and rapid isocratic reversed-phase high performance liquid chromatography (RP-HPLC) method was developed and validated as per International Conference on Harmonisation (ICH) and United States Pharmacopeia (USP) guidelines for analysis of tiagabine in the presence of its degradation products. The chromatographic separation was achieved on a Vision HT C18 column (150 mm × 4.6 mm, 5 μm) with mobile phase comprising of 11.5 mM sodium dihydrogen phosphate buffer (adjusted to pH 2.0 with orthophosphoric acid)/acetonitrile (50:50, v/v) at a flow rate of 1 mL/min and the UV detection wavelength was set at 254 nm. Stress degradation studies were performed as stated in ICH guidelines on tiagabine bulk drug using acid, base, oxidation, heat and light. The method was validated in accordance to system suitability, linearity and range, specificity, accuracy, precision, limit of detection (LOD), limit of quantitation (LOQ), and robustness. Tiagabine was found to degrade under acidic, photolytic, oxidative and thermal condition, but stable under basic hydrolysis condition. The developed method was found to be linear in the concentration range of 50-150 μg/mL (r2 = 0.9983) and the percentage recovery for the accuracy was 98.86-99.35%. The LOD and LOQ obtained were 31.93 μg/mL and 96.76 μg/mL, respectively while the %RSD for precision, robustness and stability studies were less than 2%. The degradation products formed from the stress degradation studies were well separated from tiagabine and hence the method could be regarded as stability indicating. The proposed method can be used in the analysis of tiagabine bulk drug and pharmaceutical formulations in quality control laboratories. Keywords: Tiagabine, RP-HPLC, Stress degradation studies, Validation.en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14377/32064
dc.language.isoenen_US
dc.publisherInternational Medical Universityen_US
dc.subjectChromatography, High Pressure Liquiden_US
dc.subjectLimit of Detectionen_US
dc.subjectHydrolysisen_US
dc.subjectDrug Dosage Calculationsen_US
dc.titleDEVELOPMENT OF A VALIDATED RP-HPLC METHOD FOR THE DETERMINATION OF TIAGABINE AND ITS DEGRADED FORMS IN BULK AND PHARMACEUTICAL DOSAGE FORMSen_US
dc.typeThesis
dspace.entity.typePublication
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
output.pdf
Size:
984.71 KB
Format:
Adobe Portable Document Format
Description:
Final Thesis
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: